Found 14 results
Filters: Keyword is Prospective Studies  [Clear All Filters]
2023
Homssi M, Sweeney EM, Demmon E, Mannheim W, Sakirsky M, Wang Y, Gauthier SA, Gupta A, Nguyen TD.  2023.  Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI.. AJNR Am J Neuroradiol. 44(6):649-655.
2019
Steele CM, Mukherjee R, Kortelainen JM, Pölönen H, Jedwab M, Brady SL, Theimer KBrinkman, Langmore S, Riquelme LF, Swigert NB et al..  2019.  Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal Dysphagia: Results from a Prospective Exploratory Study.. Dysphagia. 34(5):698-707.
Merkies ISJ, van Schaik IN, Léger J-M, Bril V, van Geloven N, Hartung H-P, Lewis RA, Sobue G, Lawo J-P, Durn BL et al..  2019.  Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.. J Peripher Nerv Syst. 24(1):48-55.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Patsalides A, Oliveira C, Wilcox J, Brown K, Grover K, Gobin YPierre, Dinkin MJ.  2019.  Venous sinus stenting lowers the intracranial pressure in patients with idiopathic intracranial hypertension.. J Neurointerv Surg. 11(2):175-178.
2018
Walters MJ, Sterling J, Quinn C, Ganzer C, Osorio RS, Andrews RD, Matthews DC, Vallabhajosula S, de Leon MJ, Isaacson RS et al..  2018.  Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.. BMJ Open. 8(11):e023664.
2017
Vo ML, Chin RL, Miranda C, Latov N.  2017.  Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.. Muscle Nerve. 56(4):732-736.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..  2017.  Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
2016
Chiang GC, Pinto S, Comunale JP, Gauthier SA.  2016.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.. J Neuroimaging. 26(3):289-95.
2012
Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han X-M, Venkataraman A et al..  2012.  Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.. J Neurol Sci. 315(1-2):49-54.
1983
Roten A, Altorfer J, Frösner GG, Pirovino M, Grob PJ, Schmid M.  1983.  [Course spectrum of hepatitis A. Relation to epidemiologic, biochemical and histological findings in hospitalized patients].. Schweiz Med Wochenschr. 113(19):694-700.